Login to Your Account



Theravance prices $94.1M offering at $21 per share

By Michael Fitzhugh
Staff Writer

Friday, April 29, 2016

Theravance Biopharma Inc. priced an upsized $94.1 million public offering on Friday, saying it would sell about 4.77 million shares at $21 each as it moves to build a strong balance sheet capable of supporting two key development programs.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription